China Health Technology Group Holding Company Limited (CN Health Tech) has announced that its board of directors will convene on 30 September 2026 to review and approve the Group’s audited financial results for the fiscal year ended 30 June 2026. The agenda also includes deliberation on the payment of a final dividend, if any.
The meeting notice, released on 17 September 2026, confirms that decisions taken will be disclosed through an official results announcement following board approval.
The Board currently comprises three executive directors—Chairman and Executive Director Bi Xue, Leung Ka Wai, and Wong Hoi Ying—and three independent non-executive directors—Chau Wing Nam, Liu Shuhua, and Li Liangjie.
Comments